These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9414286

  • 1. Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells.
    Gardiner CM, Meara AO, Reen DJ.
    Blood; 1998 Jan 01; 91(1):207-13. PubMed ID: 9414286
    [Abstract] [Full Text] [Related]

  • 2. Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity.
    Gardiner CM, Reen DJ.
    Immunology; 1998 Apr 01; 93(4):511-7. PubMed ID: 9659223
    [Abstract] [Full Text] [Related]

  • 3. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells.
    Lee SM, Suen Y, Chang L, Bruner V, Qian J, Indes J, Knoppel E, van de Ven C, Cairo MS.
    Blood; 1996 Aug 01; 88(3):945-54. PubMed ID: 8704253
    [Abstract] [Full Text] [Related]

  • 4. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 01; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-beta inhibits lymphokine activated killer cytotoxicity of bone marrow cells: implications for the graft-versus-leukemia effect in irradiation allogeneic bone marrow chimeras.
    Billiau AD, Sefrioui H, Overbergh L, Rutgeerts O, Goebels J, Mathieu C, Waer M.
    Transplantation; 2001 Jan 27; 71(2):292-9. PubMed ID: 11213076
    [Abstract] [Full Text] [Related]

  • 6. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood.
    Qian JX, Lee SM, Suen Y, Knoppel E, van de Ven C, Cairo MS.
    Blood; 1997 Oct 15; 90(8):3106-17. PubMed ID: 9376592
    [Abstract] [Full Text] [Related]

  • 7. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

  • 8. Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells.
    Margolin KA, Wright C, Forman SJ.
    Leukemia; 1997 May 15; 11(5):723-8. PubMed ID: 9180298
    [Abstract] [Full Text] [Related]

  • 9. The regulation and biological activity of interleukin 12.
    Lee SM, Suen Y, Qian J, Knoppel E, Cairo MS.
    Leuk Lymphoma; 1998 May 15; 29(5-6):427-38. PubMed ID: 9643557
    [Abstract] [Full Text] [Related]

  • 10. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R, Nagler A.
    Exp Hematol; 1998 Jul 15; 26(7):571-9. PubMed ID: 9657131
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Usefulness of lymphokine-activated killer cells generated from bone marrow mononuclear cells for the purging of residual tumor cells in peripheral blood stem cell graft.
    Komatsu F, Kajiwara M.
    Jpn J Cancer Res; 1996 Feb 15; 87(2):161-9. PubMed ID: 8609065
    [Abstract] [Full Text] [Related]

  • 16. IL-2-activated cord blood mononuclear cells.
    Derzic S, Slone V, Sender L.
    Cytotherapy; 2005 Feb 15; 7(5):408-16. PubMed ID: 16236630
    [Abstract] [Full Text] [Related]

  • 17. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4.
    Salvucci O, Mami-Chouaib F, Moreau JL, Thèze J, Chehimi J, Chouaib S.
    Eur J Immunol; 1996 Nov 15; 26(11):2736-41. PubMed ID: 8921963
    [Abstract] [Full Text] [Related]

  • 18. Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells.
    Shen RN, Lu L, Young P, Shidnia H, Hornback NB, Broxmeyer HE.
    Int J Radiat Oncol Biol Phys; 1994 Jul 01; 29(4):821-6. PubMed ID: 8040029
    [Abstract] [Full Text] [Related]

  • 19. Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow.
    Keever CA, Welte K, Small T, Levick J, Sullivan M, Hauch M, Evans RL, O'Reilly RJ.
    Blood; 1987 Dec 01; 70(6):1893-903. PubMed ID: 3118990
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxicity of human cord blood natural killer cells is enhanced by recombinant interleukin-15.
    Saghafi S, Pourfathollah AA, Kheirandish M, Azimdoust A, Behnia M, Shahjahani M, Moin M.
    Iran J Allergy Asthma Immunol; 2010 Jun 01; 9(2):69-77. PubMed ID: 20683100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.